Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEOTAX: Neoadjuvant DCF in Locally Advanced Gastric Adenocarcinoma
NCT00343239Phase 2Completed
- Sponsor
- Sanofi
- Start
- Jun 2006
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel in gastric adenocarcinoma, sponsored by Sanofi. Started Jun 2006; status: completed.
02
Drugs
docetaxel
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on NCT00343239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00343239.